Sep 13 |
Moderna Stock Falls Again. How the Drug Maker Can Turn Things Around.
|
Sep 13 |
Moderna extends losses as R&D Day updates lead to downgrades
|
Sep 13 |
A Bull Market Is Here: 2 High-Potential Stocks Down More Than 50% to Buy Right Now
|
Sep 13 |
Moderna, trailing rivals, checks its RSV shot expectations
|
Sep 13 |
ESMO: Moderna’s mRNA solid tumour vaccine shows early promise
|
Sep 13 |
Trending tickers: Boeing, Vodafone, Adobe, Moderna
|
Sep 13 |
Moderna shares slip premarket as analysts cut ratings amid guidance worries
|
Sep 12 |
S&P 500 Gains and Losses Today: Moderna Stock Plunges as Firm Plans R&D Cuts
|
Sep 12 |
Moderna Cost Cuts Fail to Restore Investor Trust
|
Sep 12 |
Moderna stock plunges nearly 20% as company reports poor COVID-19 vaccine sales and cuts to research plans
|